191 related articles for article (PubMed ID: 27233154)
1. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.
Barnard SA; Pieters M; De Lange Z
Blood Rev; 2016 Nov; 30(6):421-429. PubMed ID: 27233154
[TBL] [Abstract][Full Text] [Related]
2. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects.
Bastard JP; Vidal H; Jardel C; Bruckert E; Robin D; Vallier P; Blondy P; Turpin G; Forest C; Hainque B
Int J Obes Relat Metab Disord; 2000 Jan; 24(1):70-4. PubMed ID: 10702753
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi MC; Bastelica D; Morange P; Berthet B; Leduc I; Verdier M; Geel O; Juhan-Vague I
Diabetes; 2000 Aug; 49(8):1374-80. PubMed ID: 10923640
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
8. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.
Samad F; Loskutoff DJ
Mol Med; 1996 Sep; 2(5):568-82. PubMed ID: 8898373
[TBL] [Abstract][Full Text] [Related]
12. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.
Lijnen HR
Thromb Haemost; 2005 May; 93(5):816-9. PubMed ID: 15886793
[TBL] [Abstract][Full Text] [Related]
13. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women.
Solano MP; Perry AC; Wang X; Ross R; Goldberg RB
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):82-7. PubMed ID: 12532158
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
[TBL] [Abstract][Full Text] [Related]
16. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines.
Halleux CM; Declerck PJ; Tran SL; Detry R; Brichard SM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4097-105. PubMed ID: 10566656
[TBL] [Abstract][Full Text] [Related]
17. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.
Alessi MC; Peiretti F; Morange P; Henry M; Nalbone G; Juhan-Vague I
Diabetes; 1997 May; 46(5):860-7. PubMed ID: 9133556
[TBL] [Abstract][Full Text] [Related]
18. Re: "Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus" by Bayomi et al. (Metab Syndr Relat Disord 2017;15:269-275).
Avogaro A
Metab Syndr Relat Disord; 2017 Aug; 15(6):266-268. PubMed ID: 28605281
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
20. Visceral fat as a determinant of fibrinolysis and hemostasis.
Mertens I; Van Gaal LF
Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
